--News Direct--
OTC stocks have gained popularity recently and are catching the eye of many investors. These stocks are often considered to be riskier than their counterparts on major exchanges. However, the potential for high returns has made them an attractive option for those willing to do their research.
OTC stocks also offer investors the opportunity to get in on emerging companies and technologies at a more reasonable price than some of the major exchanges.
In this article, we’ll take a closer look at a few OTC stocks that are trending in the right direction and touch on why an investor may want to pay closer attention.
Epazz Inc. (OTC: EPAZ) is a mission-critical provider of drone technology, blockchain mobile apps, and cloud-based business software solutions.
ZenaDrone Inc., a spinoff of Epazz Inc. Holdings, is a provider of multifunctional drones equipped with machine learning systems, multispectral sensors, and AI technology. ZenaDrone uses the data captured from its cameras to create a 3D interactive environment.
A few weeks ago, EPAZ issued a press release detailing new AI upgrades to the ZenaDrone lineup. EPAZ has announced that it will be updating its artificial intelligence (AI) predictive automation software in ZenaDrone 1000 aerial technology.
The ZenaDrone team will use Predictive AI Analytics, or "predictive modeling," a type of analysis that employs methods and resources to create predictive models and make predictions of future outcomes based on acquired data.
On February 21, EPAZ announced that they are submitting over five Phase I proposals to the U.S. government under its SBIR Phase I program. SBIR Phase 1 allows small businesses with innovative products to receive US government contracts within 90 days of submission.
EPAZ says that if ZenaDrone is awarded a Phase I contract worth up to $75,000 per proposal, EPAZ will then be in a position to submit for Phase 2 contracts with a value of up to $1.2 million per contract.
According to EPAZ, ZenaDrone will gain the ability to be listed as the sole source supplier of its technology, which would allow the U.S. government to purchase the ZenaDrone 1000 without a bidding process.
CEO Shaun Passley, Ph.D., said, "We are working towards our first government contract using multiple avenues, which will hopefully lead to our first set of government customers, and through The SBIR would open us up to the whole federal government for our drone technology."
The price of EPAZ stock increased 9.09% on Wednesday, continuing a string of successful trading days.
For investors interested in the high tech and AI sectors, EPAZ offers an attractive play, with competitive technology that the company continues to improve and invest in.
HUMBL, Inc. (OTCQB: HMBL) is a digital commerce platform that connects consumers, freelancers, and merchants in the digital economy worldwide.
The company has multiple products, including HUMBLPAY which connects consumers, freelancers, and merchants in the digital economy to share and pay.
HMBL also has the HUMBLMARKETPLACE, which enables merchants to list and sell goods by authenticating through the HUMBL Token Engine and HUMBL Origin Assurance technologies to improve merchants' ability to trade, track, and pay for assets, as well as HUMBL Pay web checkout integrations. It also provides HUMBLFINANCIAL, a platform that provides digital asset investment services.
On February 22, HMBL announced that they had decided to cancel their application for a 1:10 reverse split of the HMBL stock with FINRA.
HMBL withdrew the FINRA application in light of reassessing its strategic plans for a future uplist to a major stock exchange and may reapply later this year should it be necessary to do so.
“We are starting off 2023 with a detailed review of our business and making strong moves accordingly. On February 10, HUMBL launched the first mobile wallet with digital assets, a search engine, and verified social media profiles in one application. Further, HUMBL is in the process of aggressively settling legacy debt and recapitalizing the company with the goal of less dilutive financing," said Brian Foote, CEO of HUMBL.
“We also revisited the purpose of the reverse split and believe it is neither aligned with our current objectives, nor particularly beneficial for our retail shareholders at this juncture.”
The stock was up as much as 11.39% on Wednesday. Keep HMBL on a watchlist to see if the momentum will continue.
International Endeavors Corporation (OTC: IDVV) is an alternative energy company that is centered on solar technology, battery storage, bi-directional charging, and clean energy crypto mining rigs in the US and Latin America.
The business disclosed on Wednesday that it had acquired WITech, a small business specializing in automation and artificial intelligence (AI) technologies.
International Endeavors Corporation will be able to advance its current solar and cryptocurrency technologies as well as enter the burgeoning AI market as a result of this acquisition.
IDVV plans to use the technology in a number of ways, beginning with incorporating it into their existing clean energy cryptocurrency projects, allowing users to mine more efficiently, and automating processes.
IDVV also plans to establish a wholly owned subsidiary for WITech to use the technology to develop a variety of products, including an automated video production platform that creates content using popular AIs and automation.
IDVV Vice President, Bill Martin, stated, "We have been building the technology segment of our company during the last year. This acquisition will allow the company to provide a better product and expand our company into other areas of growth. We look forward to announcing a video demonstration shortly."
The stock performed well on Wednesday, ending the day up 3.38%. Keep an eye out to see if investors remain interested in the stock.
Full Alliance Group (OTC: FAGI) is a diverse public holding company that acquires assets in the healthcare, nutritional, and cardiovascular healing spaces.
FAGI has not issued news in years. There is no company description, however; in the 12/31/2022 yearly filing uploaded yesterday, the company stated they will be operating in the CAM space. According to FAGI, CAM, or complementary and alternative medicine, is the term for medical products and practices that are not part of standard medical care.
FAGI will be working with ozone blood treatments. "EBO2" is a modern, high-volume blood gas exchange unit for the treatment of 5-7 liters of blood with medical ozone.
The unit allows extracorporeal blood, oxygenation, and ozone exposure, as well as blood filtration via the filter, in a unique way by using the integrated diffusing membranes within the filter fibers to trap lipids and proteins that are in excess in the venous blood supply. The EBO2 unit is considered the world's most advanced medical ozone therapy performed today.
Investors seemed to take notice, as FAGI was up 220% on Wednesday.
Disclaimers: This article contains sponsored content. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. CaptalGainsReport 'CGR' (owned by RazorPitch Inc.) is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. CGR has been compensated thirty-five hundred dollars by U.S. Critical Metals Corp to produce content related to USCMF. As part of that content, readers, subscribers, and webs are expected to read the full disclaimers and financial disclosure statement that can be found on our website.
CapitalGainsReport is a financial website and newsletter for investors seeking nanocap and microcap opportunities. Please join our free newsletter at CapitalGainsReport.com
Contact Details
Mark McKelvie
+1 585-301-7700
Company Website
https://capitalgainsreport.com/
View source version on newsdirect.com: https://newsdirect.com/news/capitalgainsreport-otc-stocks-poised-to-pop-epaz-hmbl-idvv-fagi-572553398
